President Rodrigo Duterte's threat against the United States that he would terminate the Visiting Forces Agreement if the latter fails to deliver at least 20 million vaccines in the country might be a bad move, Senator Panfilo Lacson said Monday.
By DONA MAGSINO, GMA News
Published December 28, 2020 11:35am An official and published scientific report on the efficacy rate of the COVID-19 vaccine developed by Chinese biopharmaceutical company Sinovac is yet to be released, Food and Drug Administration (FDA) director general Eric Domingo said Monday amid misgivings about the brand. In an interview on CNN Philippines, Domingo explained that Sinovac s clinical trial has several arms in different countries and that the efficacy rate varies. The efficacy rate of Sinovac s COVID-19 vaccine in Brazil is at least 50%, while it was over 90% in Turkey, according to the FDA chief. We really have to wait for the actual interim scientific report on the clinical trial Phase 3. I haven t seen any, Domingo said, noting that the firm is expected to come up with a consolidated report on results.
Pfizer-BioNTech, Moderna COVID-19 vaccines possibly Philippines first JOVILAND RITA,GMA News A dose of the COVID-19 vaccine developed by BioNTech and Pfizer is pictured in this undated handout photo in Mainz, Germany. BioNTech SE 2020, all rights reserved/Handout via REUTERS COVID-19 vaccines from Pfizer-BioNTech and Moderna could be the first ones to be made available in the country if negotiations prosper, an official of the Department of Science and Techology said Thursday. In a public briefing, DOST–Philippine Council for Health Research Development executive director Jaime Montoya said the possibility of making available the vaccines from the two firms was based on their application for emergency use authorization (EUA).
The result of over 50% efficacy of Sinovac ‘s COVID-19 vaccines in a late-stage trial in Brazil meets the minimum requirement of the World Health Organization (WHO), an official of the Department of Science and Technology (DOST) said.
By JOVILAND RITA, GMA News
Published December 24, 2020 1:18pm COVID-19 vaccines from Pfizer-BioNTech and Moderna could be the first ones to be made available in the country if negotiations prosper, an official of the Department of Science and Techology said Thursday. In a public briefing, DOST–Philippine Council for Health Research Development executive director Jaime Montoya said the possibility of making available the vaccines from the two firms was based on their application for emergency use authorization (EUA). “If they are going to pursue their application for the EUA in the Philippines, malamang sila ang mauuna na maging available,” Montoya said.